Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
A laboratory test is conducted to identify the presence of viruses belonging to the orthopoxvirus genus, which includes notable species such as monkeypox virus, cowpox virus, and vaccinia virus. These viruses are characterized as large, enveloped, double-stranded DNA viruses that have a particular affinity for infecting epidermal cells. Infections caused by orthopoxviruses can manifest in various ways, ranging from localized skin infections to more widespread systemic infections. The initial site of infection is typically the skin or mucosal surfaces, and in some cases, the respiratory tract may also be involved. This can lead to the development of characteristic pock lesions and symptoms associated with viremia as the virus disseminates through the lymphatic system throughout the body. To perform the test, a swab sample is collected from a skin lesion, which is then used to isolate viral DNA. The polymerase chain reaction (PCR) technique is employed to amplify the DNA target sequence, resulting in millions of copies of the viral DNA. This process involves the addition of amplification primers, which are short, synthetic strands of nucleic acid that are complementary to specific regions of the target nucleic acid fragment. These primers bind to the target DNA, allowing the polymerase enzyme to replicate the region and synthesize new nucleic acid. The amplified product fluoresces, enabling the detection and confirmation of the presence of the orthopox virus in the sample.
© Copyright 2026 Coding Ahead. All rights reserved.
The procedure is indicated for the detection of infections caused by orthopoxviruses, which may present with various symptoms and conditions. The following are specific indications for performing this test:
The procedure for detecting orthopoxvirus involves several critical steps, each designed to ensure accurate identification of the viral DNA. The following outlines the procedural steps:
Post-procedure care involves monitoring the patient for any immediate reactions to the sample collection. The results of the test are typically available within a specified timeframe, allowing for timely diagnosis and management of the suspected orthopoxvirus infection. It is essential for healthcare providers to communicate the results to the patient and discuss any necessary follow-up actions or treatments based on the findings. Additionally, proper documentation of the procedure and results is crucial for compliance and future reference.
| Short Descr | ORTHOPOXVIRUS AMP PRB EACH | Medium Descr | IADNA ORTHOPOXVIRUS AMPLIFIED PROBE TECHNIQUE EA | Long Descr | Infectious agent detection by nucleic acid (DNA or RNA); Orthopoxvirus (eg, monkeypox virus, cowpox virus, vaccinia virus), amplified probe technique, each | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | CLIA Waived (QW) | No | APC Status Indicator | Service Paid under Fee Schedule or Payment System other than OPPS | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | none | MUE | 4 |
| 59 | Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25. | 90 | Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number. |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2024-01-01 | Added | First appearance in codebook. |
| 2024-01-01 | Note | Grammar correction on long description. |
| 2022-07-26 | Added | Code added. |
Get instant expert-level medical coding assistance.